Vildagliptina/Metformina Cinfa

Vildagliptina/Metformina Cinfa combines two active ingredients to support blood sugar control in adults with type 2 diabetes. This oral medication is prescribed when diet and exercise alone are insufficient. It helps maintain healthy glucose levels throughout the day. Suitable for patients requiring dual therapy.

Vildagliptina/Metformina Cinfa is used to improve blood sugar levels in adults with type 2 diabetes. It combines metformin, which reduces glucose production in the liver, with vildagliptin, which enhances insulin release after meals. This combination therapy is typically prescribed when diet and exercise have not been enough to control blood sugar. It is not intended for type 1 diabetes or diabetic ketoacidosis.

This medication helps maintain more stable blood sugar levels throughout the day by working on two different pathways in the body. Users may notice improved energy levels and reduced symptoms related to high blood sugar, such as excessive thirst or frequent urination. Effects can vary, and consistent use is important for best results.

Store in a cool, dry place away from direct sunlight and out of reach of children. Keep the original packaging until the medication is fully used to ensure proper identification. If you experience persistent nausea, stomach upset, or signs of low blood sugar, consult a healthcare professional. Regular blood sugar monitoring is recommended while taking this medication.

This medication may interact with alcohol, increasing the risk of lactic acidosis or low blood sugar. Certain medications, such as diuretics, corticosteroids, or other diabetes treatments, may affect its effectiveness. Always inform your healthcare provider about all medications, supplements, or herbal products you are using before starting this treatment.